Pakistan has launched an online system with a new registration process of cardiac stents to regulate the counterfeit medicine market, a news report has revealed.
According to The Nation, the new registration process requires that the company that imports cardiac stents must register the product with Drug Regularity Authority Pakistan (DRAP) for it to be accessible on the website. This will be in addition to restricting the access of the website data to users registered with DRAP.
“Only authorized stents will be made accessible for patients through this system,” Sajid Shah, Spokesperson of the Ministry of National Health & Regulation Services (NHS), told the magazine.
The new online system requires the record of patient and the stent with DRAP in order to carry out the treatment. “The provided data will be matched with the registration form to ensure the transparency,” an official reported to the magazine on Tuesday.
It has been reported that the Federal Investigation Agency (FIA) in Pakistan has been investigating the counterfeit stents sold within the country since 11 Chinese companies were found selling these illegal medicines for import prices between Rs2,000 and Rs4,000 per stent, however selling them to patients for between Rs100,000 and Rs250,000.
Extensive measures have been taken in order to enhance the safety protocols and to control the counterfeit market of cardiac stents within Pakistan.